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Edited by Horst FeldmannAbstract The mouse polymerase delta-interacting protein 1
gene, PDIP1, is mapped to chromosome 7F3 region, spans
approximately 16.7 kb, and is organized into six exons. The
transcription start site (TSS) was determined to be G, corre-
sponding to position of 162-bp upstream of the translation start
codon. The promoter region was found to lack TATA box or
CCAAT box, instead, a CpG island was detected surrounding
TSS. The region from 162 to +114 is required for basal tran-
scriptional regulation of mouse PDIP1 gene, contains two AP-2
and two Sp1 binding sites. The Sp1 site upstream of TSS acti-
vates, while the other Sp1 site and two AP-2 sites suppress the
transcription activity of mouse PDIP1 gene.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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AP-21. Introduction
Human polymerase delta-interacting protein 1 (PDIP1) was
demonstrated to co-localize with DNA polymerase d (pol d)
and proliferating cell nuclear antigen (PCNA) at replication
foci, physically and functionally interact with both proteins,
and stimulate pol d activity in the presence of PCNA [1].
The expression of human PDIP1 gene has been detected in
every tissue tested, including liver, colon, thymus, kidney,
small intestine, placenta, lung and leukocyte.
We recently cloned two rat genes homologous to human
PDIP1, termed rat PDIP1 and rat tumor necrosis factor-
induced protein 1 (TNFAIP1). The deduced protein of rat
PDIP1 shares 92.7% identity with human PDIP1 protein while
the rat PDIP1 and rat TNFAIP1 share 63.1% sequence iden-
tity with each other [2]. The PDIP1 family of proteins was
quite conserved and distributed in various species of organisms
including protozoan parasites (Schistosoma japonicum),
Caenorhabditis elegans, insects (e.g., Anopheles gambiae,Abbreviations: PDIP1, polymerase delta-interacting protein 1; PCNA,
proliferating cell nuclear antigen; RACE, rapid ampliﬁcation of cDNA
ends; TSS, transcription start site; AP-2, activation protein-2; Sp1,
speciﬁcity protein 1; EMSA, electrophoresis mobility shift assay
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doi:10.1016/j.febslet.2005.02.027Drosophila melanogaster), ﬁsh (e.g., Danio rerio) and mam-
mals. Both PDIP1 and TNFAIP1 proteins contain a conserved
BTB/POZ domain at the N-terminus and a PCNA binding
motif (QTKV-EFP) at the C-terminus of the proteins, respec-
tively, and both proteins interact with PCNA and stimulate
pol d activity in a PCNA-dependent way [2].
Both human PDIP1 and TNFAIP1 are induced by tumor
necrosis factor-alpha (TNF-a) [1,3]. TNF-a is a multifunc-
tional cytokine which is involved in a variety of biological
activities, such as apoptosis, proliferation, B cell activation,
and some inﬂammatory responses [4]. One of TNF-as func-
tions is triggering hepatocyte proliferation during liver regen-
eration [5,6]. It has been shown that the activation of
hepatocyte proliferation by TNF-a is mediated through an
IL-6-dependent pathway, leading to induction of the transcrip-
tion factor Stat3 and ultimately to DNA synthesis [7]. Giving
the evidence that PDIP1 is inducible by TNF-a and IL-6, stim-
ulates pol d activity, it is quite possible that PDIP1 may play
roles in liver regeneration by linking the TNF-a signal and
DNA synthesis. Recently, Link et al. [8] engineered transgenic
C. elegans Alzheimers disease (AD) model to express the hu-
man amyloid peptide (Ab). In this transgenic C. elegansmodel,
expression of TNFAIP1 gene in AD brain was found to be ro-
bustly induced, and the brain region with the least pathology
had the highest expression of TNFAIP1, suggesting that the
TNFAIP1 plays protective roles during the process of develop-
ing AD [8]. These studies indicate that PDIP1 and related pro-
teins play critical roles in both developmental and disease
processes.
Till now, it has not been reported how the expression of
PDIP1 and related genes are regulated. As a ﬁrst step to
understand that, we cloned the cDNA and promoter of mouse
PDIP1 gene. We identiﬁed that transcription factors Sp1 and
AP-2 are critical factors to regulate the basal transcription of
mouse PDIP1 gene.2. Materials and methods
2.1. Materials
SMARTe rapid ampliﬁcation of cDNA ends (RACE) cDNA
ampliﬁcation kit, pCMVb, pTAL-Luc were purchased from Clontech
(CA, USA). Luciferase assay system and primer extension kit were
from Promega (WI, USA). CycleReadere DNA sequencing kit was
from MBI Fermentas (Lithuania). All restriction endonucleases and
ligase were from TaKaRa (Dalian, China). DMEM was from Invitro-
gen/Gibco (CA, USA). Glutathione Sepharose beads and pGEX-4T-2blished by Elsevier B.V. All rights reserved.
Table 1
Oligonucleotides used for promoter mutagenesis and electrophoretic
mobility shift assay (EMSA)
Name Sequence (50–3 0) Purpose
WtAP-2(U) CCCCAACCCGCAGGCTGGACT EMSA
MtAP-2(U) CCCCAACttGCAGaCTGGACT Mutagenesis/
EMSA
WtAP-2(D) GACGCGGCCCTCGGCCTGGCC EMSA
MtAP-2(D) GACGCGGttCTCGaCCTGGCC Mutagenesis/
EMSA
WtSp1(U) TCTTGGCTCCGCCCCCGAGACG EMSA
MtSp1(U) TCTTGGCTCCGatCCCGAGACG Mutagenesis/
EMSA
WtSp1(D) GCGATGGGGCGGCTGGTGGACG EMSA
MtSp1(D) GCGATGGtaCGGCTGGTGGACG Mutagenesis/
EMSA
HMT GATCGAACGGACCGCCCGCGGCCCGT EMSA
SV40 ATTCGATCGGGGCGGGGCGAGC EMSA
Note: Only the sense strands are shown.
Putative binding sites were underlined.
The lowercase letters denote mutated nucleotides.
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ionic polymer transfection Reagent was from Sunma Biotech Co (Xia-
men, China). Sensicripte reverse transcriptase and QIAquicke
nucleotide removal Kit was from Qiagen (Germany). All other
reagents were of analytical grade.
2.2. Rapid ampliﬁcation cDNA ends
The 5 0-RACE and 3 0-RACE were performed using SMART RACE
cDNA ampliﬁcation kit according to the manufacturers instruction.
In brief, 1 lg of total RNA extracted from mouse liver tissue was re-
verse-transcribed with oligo (dT)-anchor primer, and with oligo (dT)
primer and 5 0-anchor oligonucleotide provided in the kit for 3 0- and
5 0-RACE, respectively. Then, 5 0-RACE and 3 0-RACE were performed
with universal primer provided in the kit and gene-speciﬁc primer
(GSP) (GSP for 5 0-RACE: 5 0-CTGGCACTCTCAGGCAGTGG-
CAC-3 0, GSP for 3 0-RACE: 5 0-GACGATGAAGAGAACCGAGAG-
CACC-3 0). To conﬁrm the 5 0- and 3 0-RACE products, nested PCR was
performed with nested universal primer provided in the kit and nested
gene-speciﬁc primer (NGSP) (NGSP for 5 0-RACE: 5 0-CCCGC-
GTCTGTGAGCACTTCAAC-3 0, NGSP for 3 0-RACE: 5 0-GCCA-
TATCACCCACGATGAGCGTC-30). The ﬁnal products were cloned
into pMD18-T vector and sequenced.
2.3. Primer extension
Primer extension assay was performed using primer extension kit
according to the manufacturers instruction. Brieﬂy, an anti-sense pri-
mer (5 0-CCACTCTCCACAGCTACTCCGC-30) corresponding to the
position from +33 to +54 was labeled with [c-32P]ATP using T4 poly-
nucleotide kinase. The labeled primer was incubated with 10 lg of total
RNA from NIH3T3 or mouse liver for 30 min at 62 C and then ex-
tended with AMV reverse transcriptase for 40 min at 42 C. Simulta-
neously, sequencing reaction with the same primer as primer
extension was performed using CycleReadere DNA Sequencing kit.
The primer extension product was analyzed on a sequencing gel next
to the sequencing reaction product.
2.4. Cloning of the putative PDIP1 promoter and construction of deletion
and mutant reporter plasmids
By searching mouse genome database using the cDNA sequence of
PDIP1 gene, we identiﬁed a mouse genomic chromosome 7 clone
(NT_039435.2) comprising the whole PDIP1 gene including the puta-
tive promoter. A 1185 bp of genomic region (1071 to +114) upstream
of the translation start codon ATG was ampliﬁed from mouse genomic
DNA using primer pairs with KpnI site (underlined) at the 5 0 end of the
forward primers and HindIII site at the 5 0 end of reverse primers (For-
ward: 5 0-GGGTACCGGTGACAGAGTTGGAGAAG-3 0, Reverse:
5 0-CAAGCTTGTCCGGTTCCCTGAGATC-3 0). The ampliﬁed frag-
ment was inserted upstream of the promoterless ﬁreﬂy luciferase gene
in the KpnI/HindIII sites of pTAL-Luc vector, denoted p(1071/
+114)-luc.
A series of unidirectional 5 0-deletion constructs were generated
through diﬀerent restriction enzyme digestion and self-ligation of
p(1071/+114)-luc: p(787/+114)-luc (PvuII), p(663/+114)-luc
(SacI), p(293/+114)-luc (ApaLI), p(162/+114)-luc (BamHI), p(+6/
+114)-luc (BssHII). Site-directed mutagenesis of the p(162/+114)-
luc construct was performed by overlapping extension PCR [9]. Brieﬂy,
in the ﬁrst round, two PCR reactions in parallel were performed using
p(162/+114)-luc construct as template: one with a wild-type sense
primer corresponding to vector sequence upstream of insert
(5 0-CAAGTGCAGGTGCCAGAACAT-3 0) and a mutated antisense
primer, the other with a mutated sense primer (complementary
to the mutated antisense primer) and a wild-type antisense primer
corresponding to vector sequence downstream of insert (5 0-
GTCTTCCATG-GTGGCTTTACC-30). The mixture of the above
two PCR products was used as template for further PCR reaction
using the wild-type sense primer and the wild-type antisense primer.
The ﬁnal PCR product was subcloned into upstream of the promoter-
less ﬁreﬂy luciferase gene at KpnI/HindIII sites of pTAL-Luc vector.
The mutated sense and antisense primers sequences used in site-direc-
ted mutagenesis are given in Table 1. The promoterless luciferase
control reporter vector pLuc-control was constructed through deleting
the TATA-like promoter by BglII/HindIII digestion and self-ligation
of pTAL-Luc. All the above constructs were conﬁrmed by DNA
sequencing.2.5. Computer analysis
The promoter region was predicted by PromoterInspector program
(www.genomatix.de) and Proscan (www-bimas.cit.nih.gov). Transcrip-
tion factor binding sites were predicted by PromoterInspector program
and MatInspector program (www.genomatix.de), which uses TRANS-
FAC matrices (core similarity 1.0 and matrix similarity 0.9). The pres-
ence of CpG islands was analyzed with the EMBOSS program
CpGplot (www.ebi.ac.uk). According the program, a CpG island is de-
ﬁned as stretches of DNA in which the average percentage of G plus C
nucleotides is over 50%, the calculated observed/expected CpG ratio is
over 0.6 and the conditions hold for a minimum of 200 bases.
2.6. Cell culture, transient transfection and luciferase reporter assays
NIH3T3 or HepG2 cells were grown in DMEM supplemented with
10% newborn calf serum, L-glutamine (2 mM), penicillin (100 U/ml)
and streptomycin (100 lg/ml) at 37 C in a 5% CO2 incubator. Cells
were seeded in 35 mm dish and transfected at 70% conﬂuence using
Sofaste Cationic Polymer Transfection Reagent according to the
manufacturers manual. Brieﬂy, 1.5 lg of luciferase reporter plasmid
were co-transfected the cells with 0.5 lg of b-galactosidase expression
vector pCMVb which was used as an internal control to normalize the
transfection eﬃciency. At 36 h after transfection, the cells were lysed to
measure the luciferase activity using the Luciferase Assay System. The
luciferase activities were normalized according to b-galactosidase
activities.
2.7. Plasmids construction and expression of mouse Sp1 and AP-2a
The coding sequence of mouse Sp1 was ampliﬁed from mouse spleen
cDNA using primer pair with EcoRI site (underlined) at the 5 0 end of
the forward primers and SalI site at the 5 0 end of reverse primers (For-
ward: 5 0-AGAATTCCTGCCACCATGAGCGACCA-3 0, Reverse:
5 0-CGTCGACCTAATCTTAGAAACCATTGCCACTG-3 0), cloned
into pCMV-HA and pGEX-4T-2 at EcoRI/SalI, respectively. The cod-
ing sequence of mouse AP-2a was ampliﬁed from mouse brain cDNA
using primer pair (Forward: 5 0-GGAATTCAAATGCTTTGGAA-
ACTGACG-3 0, Reverse: 5 0-GCTCGAGGAGAGCCTCACTTTCT-
GTG-3 0), cloned into pCMV-HA and pGEX-4T-2 at EcoRI/XhoI
sites, respectively. The resulting constructs were sequenced to conﬁrm
the orientation and sequence. The pCMV-Sp1 and pCMV-AP2a were
used to express Sp1 and AP-2a in mammalian cells. The pGEX-4T-2-
Sp1 and pGEX-4T-2-AP2a were transformed into Escherichia coli
BL21, respectively, and GST-fusion proteins were expressed with
IPTG induction and puriﬁed by Glutathione Sepharose beads.
2.8. Electrophoretic gel mobility shift assays
The oligonucleotides containing wild-type or mutated putative tran-
scription factor binding site were synthesized (Table 1). The forward
oligonucleotides were end-labeled with [c-32P]ATP using T4 polynucle-
otide kinase and puriﬁed using the QIAquick Nucleotide Removal Kit.
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gonucleotide were combined and heated to 95 C for 10 min and then
cooled slowly to room temperature. Binding reactions (15 ll) con-
tained 5 pmol labeled probe, 10 mM HEPES (pH 8.0), 60 mM KCl,
4 mM MgCl2, 0.1 mM EDTA, 100 lg/ml BSA, 0.25 mM DTT, 10%
glycerol and 50 pmol puriﬁed recombinant protein, were incubated
for 20 min at 37 C, and then resolved on 6% non-denaturation poly-
acrylamide gels. Gels were dried, exposed to Kodak X-ray ﬁlm at
80 C, and signals were detected by autoradiography. Competition
reactions were performed by preincubating the recombinant protein
with 10- or 50-fold molar excess of unlabeled competitor DNA prior
to addition of the radioactive probe. The wild-type consensus se-
quences of AP-2 binding site at human metallothionein IIa promoter
and Sp1 binding site at SV40 early promoter [10] were synthesized as
competitor DNA (Table 1).3. Results
3.1. Cloning of mouse PDIP1 cDNA
Through searching human PDIP1 cDNA sequence against
mouse EST database, we found two overlapping EST sequences
(GenBank Accession Nos: AI849007 and AA546545), which
shared signiﬁcant homology with human PDIP1 and could be
assembled into a contig of 1006 bp. To conﬁrm the sequence
of the contig, PCR was performed using liver cDNA and a pair
of primers (Forward: 5 0-GTTGA-AGTGCTCACAGACGC-
3 0, Reverse: 5 0-AGGTCAGTCCT-TGAAGACAATC-3 0) cor-
responding to the 5 0-end sequence of AI849007 and 3 0-end
sequence of AA546545, respectively. The ampliﬁcation product
was cloned into pMD18-T vector and sequenced. Based on the
sequence of the contig, we designed 5 0- and 3 0-RACE primers to
extend 5 0- and 3 0-end sequences by RACE-PCR. Then, the
5 0-ﬂanking sequence, 3 0-ﬂanking sequence and the contig
sequence were assembled into the full-length cDNA of mouse
PDIP1.
The full length cDNA contains an open reading frame
encoding 329 amino acids. Amino acid alignment revealed
98.8% identity between mouse PDIP1 and rat PDIP1, 91.8%
identity between mouse PDIP1 and human PDIP1. The se-Fig. 1. The genomic organization of mouse, rat and human PDIP1 genes. E
boxes represent the 5 0- and 3 0-untranslated regions.
Table 2
Exon–intron boundaries of the mouse PDIP1 gene
Exon number Exon size (bp) Splice acceptor site
1 406
2 170 accccaccagGTTGGGTGC
3 90 tcctctccagCAAAAAAGG
4 53 ctccctacagCCTGTGGTG
5 196 tggttctcagCACTTCAGA
6 747 ccttttgcagGTGGAATTC
Note: The exonic and intronic sequences are upper and lower case, respectiv
Each intron begins with a GT and ends with an AG.quence data of mouse PDIP1 are deposited in GenBank with
Accession No: AF534881.3.2. Genomic structure and transcription start site of mouse
PDIP1
To determine the genomic structure of mouse PDIP1, the
mouse genome database was searched with mouse PDIP1
cDNA. BLAST analysis showed that mouse PDIP1 is mapped
to chromosome 7F3 region, spans approximately 16.7 kb, and
is organized into six exons. The ﬁrst exon contains 5 0-untrans-
lated region and translation initiation site. The exon 2 and
exon 3 are separated by the largest intron (>10 kb). Exon 1–
6 encode the open reading frame, exon 6 also encodes the
3 0-untranslated long sequence of mouse PDIP1 (Fig. 1).
The polyadenylation signals (AATAAA) was identiﬁed in the
untranslated region of the last exon. All exon–intron bound-
aries were deﬁned to conform to the GT/AG splice donor/
receptor rule [11] (Table 2). The mouse, rat and human PDIP1
genes are of similar size, have exons of the same length, and
possess the same splice junction sites (Fig. 1).
Primer extension assay was performed to determine the tran-
scription start site (TSS). An anti-sense primer located in 1st
exon was end-labeled with [c-32P]ATP, extended with AMV re-
verse transcriptase and total RNA from NIH3T3 or mouse li-
ver. A 54-bp band was detected in both primer extension
products using RNA of NIH3T3 or liver. Simultaneously,
sequencing reaction with the same primer as primer extension
determined that the TSS is G, corresponding to position of
162-bp upstream of the translation start codon (Fig. 2).
3.3. Identiﬁcation of transcriptional regulatory region of mouse
PDIP1 gene
A 1185-bp of genomic region upstream of the translation
start codon ATG was ampliﬁed and inserted into the promot-
erless luciferase reporter gene, denoted p(1071/+114)-
luc. Through diﬀerent restriction enzyme digestion and
self-ligation of p(1071/+114)-luc, a series of unidirectionalxons are indicated by boxes. Solid boxes indicate coding region, open
Splice donor site Intron size (kb)
GACGCGGGAGgtatgcgtgc 1.334
T GGCGCTGCAGgtgagagccc 10.530
G CACCTCCAAGgtgaggccct 0.088
A CTTACACCAGgtgagcgggg 0.583
T GCAGACCAAGgtcagagggg 2.542
C
ely.
Fig. 2. Mapping of the transcription start site of the mouse PDIP1
gene. 32P-labeled primer was annealed to the total RNA from NIH3T3
cells or liver tissue and extended with reverse transcriptase. The DNA
sequence ladder was obtained using the same primer and separated on
the same gel. The extended product is indicated by the arrow.
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constructs were transfected, respectively, into NIH3T3 cells
and their luciferase activities were determined. As shown in
Fig. 3B, the longest construct p(1071/+114)-luc displayed a
higher promoter activity in NIH3T3 than that of the promot-
erless luciferase control plasmid, pLuc-control. Deletion
extending to position 787 resulted in reduction of 22.3% of
promoter activity. In contrast, deletion to 663 resulted in sig-
niﬁcant increase of promoter activity. These results suggested
that positive regulatory site(s) existed in the region from
1071 to 787, and negative regulatory site(s) in the region
from 787 to 663. Further deletion extending to 293 and
162 gradually decreased the promoter activity, but the pro-
moter activities were still high: the promoter activities of con-
structs p(293/+114)-luc and p(162/+114)-luc were 121.0%
and 118.7% of that of longest construct p(1071/+114)-luc,
respectively. However, deletion of the sequence from 162 to
+6, the promoter activity dramatically decreased, only 8% of
that of p(1071/+114)-luc. All these results show that the iso-
lated 1185 bp genomic fragment (1071 to +114) of mouse
PDIP1 gene contains a functional promoter and that the core
sequence of the basal promoter is localized in the region 162
to +114.
3.4. Identiﬁcation of transcription factors potentially regulating
mouse PDIP proximal promoter activity
To identify the putative cis-regulatory elements of the basal
promoter region of mouse PDIP1 gene, the 5 0-ﬂanking se-
quence upstream of translation initiation site was inspected
by computer analysis. No TATA box or CCAAT box was
found in the promoter region, instead, a CpG island was de-
tected surrounding TSS from nucleotide 279 to +107, whichspans 386 bp long with 65.3% of GC content. Similar to mouse
gene, the 5 0-ﬂanking sequences of the rat and human PDIP1
genes also lack TATA-box, possess CpG islands.
A search for transcription factors potentially regulating
PDIP1 gene expression was performed using the MatInspector
program. We found two consensus binding sites for Sp1 (68
to 63, and +15 to +20), and two consensus binding sites for
AP-2 (123 to 115 and 52 to 44) in the basal promoter
region (Fig. 3A).
Through alignment of the 5 0-ﬂanking sequences-positions
171 to +70 (relative to mouse TSS, i.e. 333 to 93 relative
to mouse translation initiation site) of mouse PDIP1, rat
PDIP1 and human PDIP1 promoters, we found that the two
Sp1 sites are perfectly conserved regarding the sequences and
relative positions (Fig. 3C). However, though we could identify
two AP-2 binding sites in mouse and human promoters in this
region, their relative position are not highly conserved. The
two AP-2 binding sites in mouse promoter are located at posi-
tions 285 to 277 and 214 to 206 relative mouse transla-
tion initiation site, while those potential sites in human
promoter are located at positions 299 to 291 and 91 to
83 relative to human translation initiation site. We could
not identify the AP-2 binding sites in this region of rat pro-
moter. By further looking upstream sequences of rat promoter,
we could identify two potential AP-2 binding sites at positions
579 to 571 and 544 to 536 relative to rat translation ini-
tiation site. These results indicate that the regulatory mecha-
nisms for the basal transcription among the mouse, human
and rat PDIP1 genes may be conserved.
To further deﬁne the sequence elements recognized by Sp1
and AP-2, we conducted electrophoretic gel mobility shift as-
says (EMSA) using 32P-labeled probes corresponding to the
potential Sp1 and AP-2 binding motifs in mouse PDIP1 pro-
moter. As shown in Fig. 4A, both the wild-type oligonucleo-
tides wtAP-2(U) (corresponding to sequence from 129 to
109) and wtAP-2(D) (corresponding to sequence from 58
to 38) produced retarded bands with puriﬁed recombinant
AP-2-a protein, while the mutated oligonuleotides mtAP-
2(U) and mtAP-2(D) did not produce retarded bands, suggest-
ing that oligonucleotides wtAP-2(U) and wtAP-2(D) was
capable of binding recombinant AP-2a. Speciﬁcity of the bind-
ing was conﬁrmed by competition with excess wild-type
consensus sequence (hMt) of AP-2 binding site at hMtIIa pro-
moter. While 10-fold molar excess unlabeled oligonucleotides
Mt-AP-2 were added, the DNA-protein complex disappeared.
The binding of recombinant Sp1 protein to the consensus
Sp1 binding sequence in mouse PDIP1 proximal promoter
was also demonstrated by EMSA (Fig. 4B). The results
showed that wild-type oligonucleotides wtSp1(U) and
wtSp1(D) were capable of binding to recombinant Sp1 protein,
but mutated oligonucleotides mtSp1(U) and mtSp1(D) were
not.
3.5. Sp1(U) site upstream of TSS activates, whereas Sp1(D)
site and two AP-2 sites suppresses PDIP1 transcription
To test the functional signiﬁcance of Sp1 and AP-2 binding,
various reporter plasmids containing site-speciﬁc mutation in
consensus binding sites of Sp1 and AP-2 were transfected into
NIH3T3 and their activities compared with reporter expressing
the normal sequence p(162 to +114)-luc. Mutation of the Sp1
binding site upstream of TSS resulted in a 43.56% loss of
Fig. 3. (A) The sequence of 5 0-ﬂanking region (1071 to +114) of mouse PDIP1 gene. The sequences that match the consensus binding sites of
known transcription factors were boxed while the restriction sites of enzymes used in deletion mutation were underlined. Numbers indicate the
nucleotide position relative to the transcription start site. The transcription start site is G, denoted +1. (B) The plasmids containing sequentially
deleted fragments of mouse PDIP1 5 0-ﬂanking region (1071 to +114) were transfected into NIH3T3 cells. Luciferase activities were measures at
36 h post-transfection. Data (means ± S.D.) were represented as the percent activity relative to that observed in p(1071/+114)-luc. (C) Alignment of
the 5 0-ﬂanking sequences upstream of translation initiation sites of mouse PDIP1, rat PDIP1 and human PDIP1 genes. Numbers indicate the
nucleotide position relative to the translation initiation site.
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Fig. 4. Electrophoretic gel mobility shift assays. The fusion protein (A: GST-AP-2a, B: GST-Sp1) was incubated with a 32P-labeled oligonucleotide
(indicated by asterisk). The protein-DNA complexes were conﬁrmed by competition with unlabeled AP-2 consensus sequence in human
metallothionein IIa promoter (hMT) or unlabeled Sp1 consensus sequence in SV40 promoter (SV40).
1720 J. Zhou et al. / FEBS Letters 579 (2005) 1715–1722reporter activity compared to wild-type promoter p(162/
+114)-luc, while mutation of the Sp1 binding site downstream
of TSS increased promoter activity by 25.71%. Mutation of the
two Sp1 sites decreased the luciferase activity by 32.73%. These
results suggested that Sp1(U) site activates promoter activity,
whereas Sp1(D) suppresses promoter activity (Fig. 5A).
Mutations of single or both AP-2 sites increased luciferase
activities, suggesting that both AP-2 sites are negative regula-
tion regions of mouse PDIP1 promoter (Fig. 5A). To further
conﬁrm the function of AP-2 in transcriptional regulatory of
mouse PDIP1, we co-transfected AP-2-deﬁcient cells HepG2
with PDIP1 promoter plasmid p(162/+114)-luc and
pCMV-AP-2 plasmid, the promoter activities decrease with
the increasing of pCMV-AP-2 (Fig. 5B).4. Discussion
In the report, we have cloned the full-length cDNA of mouse
PDIP1 gene, characterized its genomic structure and func-
tional minimal promoter. The mouse, rat and human PDIP1
genes are very similar in their overall genomic organization
and promoter structure. The 5 0-ﬂanking regions of mouse,
rat and human PDIP1 genes lack TATA box or Inr element,
while contain a conserved cluster of CpG dinucleotides, two
Sp1 binding sites, and two AP-2 binding sites in common, sug-
gesting that mouse, rat and human PDIP1 genes have common
regulatory mechanisms. The GC-rich and TATA-less promot-
ers have been found predominantly in ubiquitously expressed
genes, and this structure is considered to be characteristic of
housekeeping genes [12,13]. The human PDIP1 was found to
be ubiquitously expressed gene, but it could be up-regulated
by TNF-a [1]. Actually, several recent results have demon-
strated that GC-rich TATA-less promoters could be highly
regulated [14,15]. The regulation of such promoter is poorly
understood. It has been shown that GC-rich promoter regions
typically lack TATA or DPE core promoter elements, but con-
tain multiple GC box motifs that are bound by Sp1 and relatedtranscription factors [16,17]. Although Sp1 is ubiquitously ex-
pressed, some evidence suggests that Sp1 expression [18], bind-
ing aﬃnity [19] and post-transcriptional modiﬁcations [20] may
be modulated, and Sp1 is involved in transcription of many
cell-type speciﬁc genes, including the monocytic speciﬁc gene
CD14 [21], the liver speciﬁc a1 acid glycoprotein gene [22].
The presence of Sp1 binding sites in CpG islands is particularly
important, and the degree of activation from Sp1 tends to be
stronger in the context of TATA-less promoters than TATA-
containing promoters [23]. Not only does Sp1 contribute to
the maintenance of hypomethylated state of CpG islands
[16,17], but it may also plays a critical role in the assembly
of the transcription start complex [24]. Our study demon-
strated the importance of Sp1 in regulating PDIP1 gene
expression for several reasons. First, two Sp1 binding se-
quences were identiﬁed in the proximal promoter region of
mouse PDIP1 gene. Second, EMSA results showed that Sp1
was capable of binding to both Sp1 sites. Third, point muta-
tion introduced at the Sp1-binding sites resulted in signiﬁcant
change in promoter activity. Especially, site-mutation of
Sp1(U) site signiﬁcantly decreased promoter activity by
43.56%, indicating that the Sp1(U) site plays a critical role
for basal promoter activity of the mouse PDIP1 gene. How-
ever, the Sp1(D) site downstream of TSS negatively regulates
the promoter activity.
In the long GC-rich region of PDIP1 promoter, we also
identiﬁed two AP-2 binding sequences. Gel shift analysis using
a radiolabelled probe corresponding to the potential AP-2
binding motif revealed direct binding of puriﬁed AP-2a protein
to the AP-2 binding motif in PDIP1 promoter. AP-2 is a tis-
sue-speciﬁc transcription factor which has been implicated as
a critical regulator of gene expression during mammalian
development, diﬀerentiation, and carcinogenesis [25].
Although AP-2 was initially described as a transcriptional acti-
vator, it has been shown to regulate negatively the transcrip-
tion of several genes, including K3 keratin [26], MX1 [15],
PAR-1 [27]. Our results also demonstrate that AP-2 functions
as repressor in transcriptional regulation of mouse PDIP1.
Fig. 5. Eﬀect of Sp1 and AP-2 sites in proximal promoter to promoter activity of PDIP1 gene. (A) Various site-mutations in Sp1 and AP-2 sites of
PDIP1 proximal promoter (162 to +114 bp) were cloned into upstream of the promoterless ﬁreﬂy luciferase, then transfected the NIH3T3 cells. The
binding sites of AP-2 and Sp1 were indicated by oval and box, respectively. The cross (X) indicates mutated site. (B) The wild-type PDIP1 promoter
plasmid p(162/+114)-luc was co-transfected HepG2 with pCMV-AP-2a plasmid. Luciferase activities were measured at 36 h post-transfection.
Data (means ± S.D.) were represented as the percent activity relative to that observed in wild-type proximal promoter.
J. Zhou et al. / FEBS Letters 579 (2005) 1715–1722 1721Mutation of both AP-2 binding motifs increase promoter
activity by 40.48% compared to wild-type promoter p(162/
+114)-luc, suggesting AP-2 suppresses promoter activity of
mouse PDIP1. The function of AP-2 in transcription regula-
tion was conﬁrmed by co-transfection of AP-2 gene and
PDIP1 promoter, we co-transfected AP-2-deﬁcient cell HepG2
with PDIP1 promoter construct p(162/+114)-luc and
pCMV-AP-2a plasmid expressing AP-2a, the promoter activi-
ties decrease with the increasing of pCMV-AP-2a.
Our data demonstrate that transcription factors Sp1 and
AP-2 are involved in transcription regulation of mouse PDIP1,
a phenomenon commonly observed in mammalian TATA-less
promoters [15,27–30], in which there are overlapping or adja-
cent Sp1 and AP-2 binding sites, with Sp1 activating and
AP-2 repressing gene transcription. In rabbit corneal epithelial
cells stimulated to diﬀerentiate, AP-2 is dramatically down-
regulated, thus altering the Sp1:AP-2 ratio and favoring the
activation of the K3 keratin gene by Sp1 in diﬀerential cells
[26]. It may be that the relative ratio of Sp1 and AP-2 in a par-
ticular cell environment determines the activation and repres-
sion of mouse PDIP1 gene. It has been shown that Sp1 is
required for the activation of TNF-a-stimulated ADAM17
[31] andMCP-1 [32] gene. PDIP1 is a TNF-a inducible protein
[1], but it is unknown how the expression of PDIP1 gene is reg-
ulated by TNF-a. We did not detect any signiﬁcant change of
PDIP1 promoter activity in NIH3T3 cells after treatment withTNF-a (data not shown). We conclude that in the proximal
promoter region we tested, there is no TNF-a responsible ele-
ment. Obviously, further studies are needed to determine by
what mechanism TNF-a induces the expression of PDIP1.
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